Tinavi Medical Technologies Co., Ltd. (SHA:688277)
China flag China · Delayed Price · Currency is CNY
13.18
-0.78 (-5.59%)
Nov 17, 2026, 3:00 PM CST

SHA:688277 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
267.87278.82178.84210.04156.19156.02
Revenue Growth
-2.31%55.90%-14.85%34.48%0.11%14.80%
Gross Profit
177.16192.17124.66138.92102.17105.98
Operating Income
-212.42-179.41-157.73-211.6-174.87-140.86
Net Income
-164.22-182.75-121.13-156.39-110.58-79.93
Earnings Per Share
-0.36-0.40-0.27-0.35-0.26-0.19
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
242.87305.8286.79360.9251.59407.74
Total Debt
207.21197.09198.54219.8998.4270.76
Net Cash (Debt)
35.66108.7188.25141.01153.17336.98
Net Cash Growth
-73.80%23.18%-37.42%-7.94%-54.55%-53.24%
Net Cash Per Share
0.080.240.200.320.360.80

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-169.97-51.17-98.65-170.5-87.51-77.76
Capital Expenditures
-29.57-29.71-36.69-221.03-59.59-238.66
Free Cash Flow
-199.55-80.88-135.34-391.53-147.1-316.42
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
66.14%68.92%69.70%66.14%65.42%67.93%
Operating Margin
-79.30%-64.35%-88.20%-100.74%-111.96%-90.28%
Pretax Margin
-52.15%-55.48%-55.66%-71.74%-92.30%-67.08%
Profit Margin
-61.30%-65.54%-67.73%-74.46%-70.80%-51.23%
FCF Margin
-74.49%-29.01%-75.68%-186.41%-94.18%-202.80%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
22.9524.8425.1028.2031.9670.64